home / stock / tgtx / tgtx short
Short Information | TG Therapeutics Inc. (NASDAQ:TGTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,586,971 |
Total Actual Volume | 48,117,555 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 379,349 |
Average Short Percentage | 15.59% |
Is there a TGTX Short Squeeze or Breakout about to happen?
See the TGTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-18-2024 | $13.99 | $13.99 | $14.63 | $13.85 | 3,483,820 | 626,314 | 17.98% |
04-17-2024 | $14.06 | $13.82 | $14.14 | $13.55 | 3,076,512 | 477,164 | 15.51% |
04-16-2024 | $13.98 | $14 | $14.17 | $13.7648 | 1,614,576 | 231,908 | 14.36% |
04-15-2024 | $14.15 | $14.07 | $14.575 | $13.945 | 2,269,304 | 356,954 | 15.73% |
04-12-2024 | $14.76 | $14.16 | $14.87 | $13.91 | 3,880,506 | 658,937 | 16.98% |
04-11-2024 | $14.81 | $14.76 | $14.99 | $14.585 | 2,242,319 | 260,353 | 11.61% |
04-10-2024 | $14.56 | $14.71 | $15.065 | $14.44 | 2,985,390 | 563,328 | 18.87% |
04-09-2024 | $15.16 | $15.1 | $15.37 | $14.976 | 1,943,180 | 370,387 | 19.06% |
04-08-2024 | $14.62 | $14.97 | $15.0266 | $14.31 | 2,003,394 | 381,220 | 19.03% |
04-05-2024 | $14.36 | $14.52 | $14.645 | $14.19 | 2,299,596 | 401,619 | 17.46% |
04-04-2024 | $14.65 | $14.46 | $14.875 | $14.38 | 2,635,213 | 439,319 | 16.67% |
04-03-2024 | $14.39 | $14.47 | $14.5881 | $14.04 | 2,289,538 | 335,468 | 14.65% |
04-02-2024 | $14.43 | $14.44 | $14.59 | $14.13 | 2,768,395 | 373,251 | 13.48% |
04-01-2024 | $15.13 | $14.77 | $15.18 | $14.65 | 2,219,609 | 356,036 | 16.04% |
03-28-2024 | $15.56 | $15.21 | $15.6 | $15.145 | 2,328,111 | 290,233 | 12.47% |
03-27-2024 | $15.55 | $15.57 | $15.615 | $15.055 | 1,454,844 | 200,075 | 13.75% |
03-26-2024 | $15.83 | $15.44 | $15.99 | $15.24 | 2,651,466 | 449,739 | 16.96% |
03-25-2024 | $15.46 | $15.69 | $15.82 | $15.4 | 1,770,918 | 259,578 | 14.66% |
03-22-2024 | $15.24 | $15.49 | $15.755 | $15.03 | 2,044,626 | 314,755 | 15.39% |
03-21-2024 | $15.55 | $15.25 | $15.79 | $15.095 | 2,156,238 | 240,333 | 11.15% |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), announced that it has been awarded a national contract with th...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI ® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at t...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced that it has been awarded a national contract with the Department of Veterans Affairs (VA) for BRIUMVI® (ublituximab-xiiy) to be the preferred agent listed on the VA National Formulary for Anti-CD20 A...